PineBridge Investments’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.3M Buy
57,087
+7,893
+16% +$3.34M 0.18% 114
2026
Q1
$23.3M Sell
49,194
-32,008
-39% -$16.1M 0.2% 104
2025
Q4
$37.9M Buy
81,202
+4,418
+6% +$2.05M 0.28% 70
2025
Q3
$32.7M Buy
76,784
+18,666
+32% +$7.23M 0.24% 93
2025
Q2
$22.3M Sell
58,118
-29,505
-34% -$10.6M 0.18% 117
2025
Q1
$30.3M Sell
87,623
-8,226
-9% -$2.65M 0.24% 91
2024
Q4
$28.8M Buy
95,849
+26,836
+39% +$9.38M 0.22% 97
2024
Q3
$28M Buy
69,013
+36,245
+111% +$13.3M 0.21% 110
2024
Q2
$10.5M Sell
32,768
-16,104
-33% -$5.23M 0.09% 220
2024
Q1
$16.3M Sell
48,872
-68,812
-58% -$21M 0.13% 174
2023
Q4
$31.9M Buy
117,684
+32,012
+37% +$7.91M 0.29% 74
2023
Q3
$21.1M Buy
85,672
+28,989
+51% +$7.93M 0.23% 112
2023
Q2
$17.2M Buy
56,683
+24,664
+77% +$6.86M 0.19% 130
2023
Q1
$8.44M Sell
32,019
-9,347
-23% -$2.37M 0.1% 217
2022
Q4
$9.93M Sell
41,366
-24,722
-37% -$5.54M 0.12% 186
2022
Q3
$12.1M Sell
66,088
-2,998
-4% -$597K 0.16% 164
2022
Q2
$11.6M Buy
69,086
+1,297
+2% +$279K 0.15% 171
2022
Q1
$17M Buy
67,789
+30,414
+81% +$7.64M 0.18% 136
2021
Q4
$9.6M Sell
37,375
-12,812
-26% -$3.14M 0.1% 207
2021
Q3
$12.2M Sell
50,187
-105,680
-68% -$25.8M 0.15% 159
2021
Q2
$32.2M Buy
155,867
+79,276
+104% +$16.2M 0.37% 61
2021
Q1
$14.4M Buy
76,591
+42,415
+124% +$7.48M 0.18% 140
2020
Q4
$5.62M Buy
34,176
+6,263
+22% +$916K 0.09% 252
2020
Q3
$3.48M Buy
27,913
+14,230
+104% +$1.76M 0.06% 292
2020
Q2
$1.33M Buy
13,683
+6,863
+101% +$713K 0.03% 399
2020
Q1
$612K Buy
6,820
+593
+10% +$76.8K 0.01% 424
2019
Q4
$920K Sell
6,227
-112,737
-95% -$15.1M 0.01% 610
2019
Q3
$14.3M Sell
118,964
-70,172
-37% -$9.07M 0.23% 118
2019
Q2
$25.6M Buy
189,136
+27,504
+17% +$3.48M 0.42% 65
2019
Q1
$21.1M Buy
161,632
+63,725
+65% +$8.56M 0.43% 65
2018
Q4
$12.2M Buy
97,907
+97,479
+22,775% +$13.1M 0.27% 106
2018
Q3
$60K Buy
428
+59
+16% +$7.34K ﹤0.01% 956
2018
Q2
$38K Hold
369
﹤0.01% 1018
2018
Q1
$36K Sell
369
-11
-3% -$1.07K ﹤0.01% 1059
2017
Q4
$33K Sell
380
-31,601
-99% -$2.54M ﹤0.01% 989
2017
Q3
$2.54M Buy
31,981
+22,356
+232% +$1.8M 0.06% 253
2017
Q2
$839K Sell
9,625
-16,301
-63% -$1.38M 0.02% 558
2017
Q1
$2.31M Sell
25,926
-88,214
-77% -$7.36M 0.06% 267
2016
Q4
$8.45M Sell
114,140
-89,671
-44% -$6.72M 0.25% 111
2016
Q3
$15.4M Buy
203,811
+33,784
+20% +$2.59M 0.68% 40
2016
Q2
$13.1M Buy
170,027
+6,349
+4% +$501K 0.67% 44
2016
Q1
$12.8M Buy
163,678
+2,713
+2% +$189K 0.66% 43
2015
Q4
$10.9M Sell
160,965
-46,385
-22% -$3.24M 0.47% 68
2015
Q3
$16M Sell
207,350
-66,256
-24% -$5.87M 0.68% 40
2015
Q2
$24.8M Sell
273,606
-85,585
-24% -$6.86M 0.98% 19
2015
Q1
$27M Buy
359,191
+212,033
+144% +$15.2M 1% 18
2014
Q4
$10.8M Buy
+147,158
New +$10.3M 0.41% 76
2014
Q1
Sell
-138,429
Closed -$6.6M 1107
2013
Q4
$6.6M Sell
138,429
-4,282
-3% -$198K 0.2% 132
2013
Q3
$6.1M Buy
142,711
+122,623
+610% +$4.79M 0.19% 142
2013
Q2
$724K Buy
+20,088
New +$777K 0.02% 344

Other funds holding HCA

PineBridge Investments's HCA Position: Q2 2026 in Review

PineBridge Investments increased its HCA Healthcare (HCA) stake by 16% in Q2 2026, buying an estimated $3.34M and bringing the position to 57,087 shares worth $22.3M. The position accounts for 0.18% of the portfolio, ranked #114.

PineBridge Investments first reported a position in HCA in Q2 2013 and has held it in 50 quarters since. The position peaked at $37.9M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • PineBridge Investments held 57,087 shares of HCA Healthcare worth $22.3M as of Q2 2026.
  • PineBridge Investments bought 7,893 HCA Healthcare shares in Q2 2026, an estimated $3.34M.
  • HCA Healthcare made up 0.18% of PineBridge Investments's portfolio in Q2 2026, its #114 holding.
  • PineBridge Investments first reported a position in HCA Healthcare in Q2 2013 and has held it in 50 quarters since.
  • PineBridge Investments's HCA Healthcare position peaked at $37.9M in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on PineBridge Investments's 13F filing for Q2 2026, filed 14 Aug 2026.